 Sara Sawyer
Concepts (555)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Evolution, Molecular | 17 | 2021 | 437 | 4.170 |
Why?
| | Primates | 18 | 2022 | 111 | 3.950 |
Why?
| | Selection, Genetic | 18 | 2021 | 243 | 2.880 |
Why?
| | Viruses | 6 | 2023 | 94 | 2.850 |
Why?
| | Virus Replication | 13 | 2022 | 395 | 2.640 |
Why?
| | HIV-1 | 11 | 2019 | 768 | 2.110 |
Why?
| | Mutation | 27 | 2023 | 3350 | 2.020 |
Why?
| | CD4 Antigens | 5 | 2019 | 124 | 1.930 |
Why?
| | Exome | 10 | 2023 | 200 | 1.880 |
Why?
| | Host-Pathogen Interactions | 9 | 2021 | 295 | 1.730 |
Why?
| | Saliva | 3 | 2023 | 189 | 1.650 |
Why?
| | Nuclear Proteins | 10 | 2020 | 592 | 1.600 |
Why?
| | Ubiquitin-Protein Ligases | 10 | 2019 | 139 | 1.580 |
Why?
| | Carrier Proteins | 11 | 2017 | 696 | 1.550 |
Why?
| | Viral Proteins | 7 | 2021 | 281 | 1.460 |
Why?
| | Carrier State | 2 | 2021 | 54 | 1.450 |
Why?
| | Receptors, Virus | 6 | 2019 | 75 | 1.390 |
Why?
| | Host Specificity | 5 | 2018 | 22 | 1.370 |
Why?
| | Sequence Analysis, DNA | 10 | 2015 | 728 | 1.360 |
Why?
| | Zoonoses | 3 | 2019 | 21 | 1.350 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 2 | 2019 | 68 | 1.210 |
Why?
| | Nuclear Pore Complex Proteins | 2 | 2018 | 31 | 1.210 |
Why?
| | Saccharomyces cerevisiae | 6 | 2018 | 477 | 1.200 |
Why?
| | Genes, BRCA1 | 5 | 2015 | 31 | 1.200 |
Why?
| | Tripartite Motif Proteins | 7 | 2019 | 30 | 1.090 |
Why?
| | Animals | 50 | 2023 | 31762 | 1.090 |
Why?
| | Receptors, Transferrin | 3 | 2015 | 22 | 1.050 |
Why?
| | Chiroptera | 3 | 2019 | 50 | 1.030 |
Why?
| | Genomics | 7 | 2022 | 639 | 1.020 |
Why?
| | Influenza A Virus, H3N2 Subtype | 2 | 2023 | 40 | 0.990 |
Why?
| | Virus Internalization | 5 | 2022 | 40 | 0.990 |
Why?
| | Amino Acid Sequence | 20 | 2019 | 1988 | 0.950 |
Why?
| | HIV Infections | 9 | 2019 | 2469 | 0.950 |
Why?
| | Saccharomyces cerevisiae Proteins | 6 | 2018 | 333 | 0.950 |
Why?
| | Intellectual Disability | 7 | 2023 | 129 | 0.940 |
Why?
| | Biological Evolution | 6 | 2018 | 416 | 0.930 |
Why?
| | Polymorphism, Single Nucleotide | 14 | 2019 | 1892 | 0.910 |
Why?
| | Repressor Proteins | 7 | 2023 | 367 | 0.890 |
Why?
| | Genome | 2 | 2019 | 272 | 0.890 |
Why?
| | Peptide Hydrolases | 3 | 2020 | 105 | 0.890 |
Why?
| | Retroelements | 2 | 2018 | 39 | 0.870 |
Why?
| | Influenza in Birds | 1 | 2023 | 3 | 0.870 |
Why?
| | Dog Diseases | 2 | 2023 | 41 | 0.860 |
Why?
| | Pan troglodytes | 3 | 2019 | 47 | 0.850 |
Why?
| | High-Throughput Nucleotide Sequencing | 7 | 2019 | 440 | 0.840 |
Why?
| | Arterivirus | 1 | 2022 | 2 | 0.840 |
Why?
| | Hemorrhagic Fevers, Viral | 1 | 2022 | 3 | 0.840 |
Why?
| | Epidemiological Monitoring | 1 | 2023 | 47 | 0.840 |
Why?
| | Cell Cycle Proteins | 5 | 2016 | 552 | 0.830 |
Why?
| | Neurofibromatosis 1 | 1 | 2023 | 36 | 0.820 |
Why?
| | Virus Diseases | 2 | 2016 | 195 | 0.820 |
Why?
| | Rhabdomyosarcoma | 1 | 2023 | 55 | 0.800 |
Why?
| | Humans | 91 | 2023 | 114757 | 0.800 |
Why?
| | RNA, Messenger | 5 | 2023 | 2557 | 0.790 |
Why?
| | RNA, Viral | 5 | 2021 | 566 | 0.790 |
Why?
| | Simian Immunodeficiency Virus | 2 | 2019 | 70 | 0.790 |
Why?
| | Genetic Variation | 8 | 2018 | 876 | 0.780 |
Why?
| | Homozygote | 3 | 2021 | 187 | 0.770 |
Why?
| | Urogenital Abnormalities | 1 | 2021 | 48 | 0.730 |
Why?
| | Congenital Abnormalities | 1 | 2021 | 73 | 0.720 |
Why?
| | Aotidae | 3 | 2019 | 7 | 0.710 |
Why?
| | Rare Diseases | 4 | 2023 | 89 | 0.710 |
Why?
| | Phylogeny | 11 | 2019 | 794 | 0.700 |
Why?
| | Computational Biology | 7 | 2020 | 530 | 0.700 |
Why?
| | Wnt Proteins | 1 | 2021 | 135 | 0.700 |
Why?
| | Interferon Type I | 1 | 2021 | 128 | 0.700 |
Why?
| | Herpesvirus 1, Human | 3 | 2018 | 76 | 0.690 |
Why?
| | Molecular Sequence Data | 17 | 2015 | 2791 | 0.690 |
Why?
| | Mammals | 4 | 2023 | 245 | 0.680 |
Why?
| | Soft Tissue Neoplasms | 2 | 2018 | 90 | 0.680 |
Why?
| | Membrane Proteins | 3 | 2018 | 1022 | 0.680 |
Why?
| | DNA-Binding Proteins | 8 | 2021 | 1314 | 0.660 |
Why?
| | Species Specificity | 9 | 2018 | 545 | 0.660 |
Why?
| | Virus Attachment | 2 | 2015 | 11 | 0.640 |
Why?
| | Polysaccharides | 1 | 2019 | 78 | 0.640 |
Why?
| | Genes, BRCA2 | 4 | 2015 | 24 | 0.630 |
Why?
| | Arenaviruses, New World | 2 | 2015 | 3 | 0.630 |
Why?
| | Transcription Factors | 4 | 2023 | 1528 | 0.620 |
Why?
| | Genetic Diseases, Inborn | 2 | 2015 | 36 | 0.610 |
Why?
| | Genes | 2 | 2015 | 224 | 0.610 |
Why?
| | Lung Diseases, Interstitial | 1 | 2023 | 507 | 0.600 |
Why?
| | Dengue Virus | 1 | 2018 | 31 | 0.600 |
Why?
| | Hamartoma Syndrome, Multiple | 1 | 2017 | 12 | 0.590 |
Why?
| | Leukoencephalopathies | 1 | 2017 | 21 | 0.590 |
Why?
| | Kidney Diseases | 1 | 2021 | 350 | 0.590 |
Why?
| | HEK293 Cells | 6 | 2019 | 594 | 0.580 |
Why?
| | BRCA1 Protein | 2 | 2014 | 56 | 0.580 |
Why?
| | DNA, Circular | 2 | 2014 | 13 | 0.570 |
Why?
| | Kidney | 2 | 2021 | 1184 | 0.570 |
Why?
| | Fibroma | 1 | 2017 | 21 | 0.560 |
Why?
| | Ribonucleoproteins | 1 | 2017 | 85 | 0.560 |
Why?
| | Cell Line | 10 | 2019 | 2639 | 0.560 |
Why?
| | Molecular Chaperones | 1 | 2018 | 157 | 0.550 |
Why?
| | Influenza A virus | 4 | 2023 | 90 | 0.550 |
Why?
| | PTEN Phosphohydrolase | 1 | 2017 | 140 | 0.550 |
Why?
| | DNA Repair Enzymes | 1 | 2016 | 22 | 0.540 |
Why?
| | Immediate-Early Proteins | 1 | 2016 | 52 | 0.540 |
Why?
| | Exoribonucleases | 1 | 2016 | 40 | 0.530 |
Why?
| | Breast Neoplasms | 6 | 2015 | 1868 | 0.530 |
Why?
| | Genetic Predisposition to Disease | 10 | 2020 | 2099 | 0.520 |
Why?
| | Base Sequence | 10 | 2017 | 2118 | 0.520 |
Why?
| | Virus Physiological Phenomena | 2 | 2012 | 6 | 0.510 |
Why?
| | Dogs | 5 | 2023 | 334 | 0.510 |
Why?
| | Lipomatosis, Multiple Symmetrical | 1 | 2015 | 1 | 0.510 |
Why?
| | Host-Parasite Interactions | 1 | 2016 | 95 | 0.510 |
Why?
| | Histones | 2 | 2017 | 536 | 0.500 |
Why?
| | GTP Phosphohydrolases | 1 | 2015 | 66 | 0.490 |
Why?
| | DNA Repair | 3 | 2014 | 186 | 0.490 |
Why?
| | Fanconi Anemia | 1 | 2014 | 11 | 0.490 |
Why?
| | Fungal Proteins | 3 | 2006 | 119 | 0.480 |
Why?
| | Recombination, Genetic | 3 | 2013 | 176 | 0.480 |
Why?
| | Genome, Human | 7 | 2020 | 351 | 0.470 |
Why?
| | Retroviridae | 5 | 2011 | 90 | 0.470 |
Why?
| | Embryonic Development | 1 | 2015 | 117 | 0.470 |
Why?
| | Multigene Family | 2 | 2013 | 193 | 0.470 |
Why?
| | Ovarian Neoplasms | 5 | 2022 | 388 | 0.470 |
Why?
| | BRCA2 Protein | 1 | 2014 | 41 | 0.460 |
Why?
| | Cerebellar Ataxia | 1 | 2014 | 7 | 0.460 |
Why?
| | Genome, Viral | 2 | 2019 | 119 | 0.450 |
Why?
| | Transcriptome | 1 | 2019 | 727 | 0.450 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2022 | 51 | 0.450 |
Why?
| | Polymorphism, Genetic | 6 | 2014 | 612 | 0.450 |
Why?
| | Abnormalities, Multiple | 3 | 2023 | 177 | 0.450 |
Why?
| | Proteins | 3 | 2016 | 912 | 0.440 |
Why?
| | Ranavirus | 1 | 2013 | 6 | 0.440 |
Why?
| | Cutis Laxa | 1 | 2013 | 2 | 0.440 |
Why?
| | Genes, Essential | 1 | 2013 | 18 | 0.440 |
Why?
| | Elastic Tissue | 1 | 2013 | 8 | 0.430 |
Why?
| | Viral Tropism | 1 | 2013 | 24 | 0.430 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 220 | 0.430 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2015 | 227 | 0.430 |
Why?
| | Antigens, CD | 1 | 2015 | 443 | 0.430 |
Why?
| | Genome, Fungal | 2 | 2018 | 28 | 0.420 |
Why?
| | Nervous System Diseases | 1 | 2015 | 252 | 0.410 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1316 | 0.400 |
Why?
| | Extracellular Matrix Proteins | 1 | 2013 | 126 | 0.400 |
Why?
| | Phenotype | 10 | 2023 | 2812 | 0.400 |
Why?
| | Circulating Tumor DNA | 2 | 2022 | 23 | 0.390 |
Why?
| | Influenza, Human | 1 | 2017 | 546 | 0.390 |
Why?
| | Neurodevelopmental Disorders | 3 | 2023 | 109 | 0.390 |
Why?
| | Plasmodium knowlesi | 1 | 2011 | 1 | 0.390 |
Why?
| | Duffy Blood-Group System | 1 | 2011 | 5 | 0.390 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2018 | 353 | 0.390 |
Why?
| | Plasmodium vivax | 1 | 2011 | 3 | 0.390 |
Why?
| | Research Design | 3 | 2014 | 931 | 0.380 |
Why?
| | Child | 19 | 2023 | 18352 | 0.380 |
Why?
| | Gene Frequency | 5 | 2011 | 481 | 0.380 |
Why?
| | Genetic Testing | 5 | 2023 | 379 | 0.380 |
Why?
| | DNA, Viral | 1 | 2013 | 350 | 0.380 |
Why?
| | Protein Binding | 8 | 2019 | 1897 | 0.350 |
Why?
| | Models, Molecular | 5 | 2017 | 1378 | 0.340 |
Why?
| | Receptors, Cell Surface | 2 | 2011 | 354 | 0.340 |
Why?
| | Growth Disorders | 2 | 2020 | 77 | 0.320 |
Why?
| | Microcephaly | 2 | 2020 | 51 | 0.320 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2011 | 368 | 0.320 |
Why?
| | Mutation, Missense | 4 | 2023 | 295 | 0.310 |
Why?
| | Alleles | 5 | 2014 | 791 | 0.310 |
Why?
| | Dengue | 2 | 2020 | 59 | 0.310 |
Why?
| | Facies | 4 | 2023 | 20 | 0.300 |
Why?
| | A549 Cells | 2 | 2018 | 51 | 0.300 |
Why?
| | Child, Preschool | 14 | 2021 | 9079 | 0.300 |
Why?
| | Sequence Alignment | 4 | 2019 | 325 | 0.300 |
Why?
| | Epidemics | 2 | 2019 | 69 | 0.300 |
Why?
| | Polymerase Chain Reaction | 4 | 2016 | 994 | 0.290 |
Why?
| | Gene Duplication | 2 | 2021 | 63 | 0.280 |
Why?
| | Viral Load | 2 | 2021 | 405 | 0.280 |
Why?
| | Germ-Line Mutation | 4 | 2023 | 130 | 0.280 |
Why?
| | Molecular Diagnostic Techniques | 2 | 2021 | 92 | 0.280 |
Why?
| | Saccharomyces | 1 | 2006 | 7 | 0.280 |
Why?
| | Haplotypes | 2 | 2005 | 453 | 0.270 |
Why?
| | Erythrocytes | 1 | 2011 | 591 | 0.270 |
Why?
| | Canada | 3 | 2022 | 322 | 0.270 |
Why?
| | Protein Structure, Tertiary | 6 | 2012 | 797 | 0.250 |
Why?
| | Genotype | 6 | 2015 | 1774 | 0.250 |
Why?
| | Replication Origin | 2 | 2004 | 15 | 0.250 |
Why?
| | Endogenous Retroviruses | 1 | 2005 | 19 | 0.240 |
Why?
| | Genes, Viral | 4 | 2013 | 89 | 0.240 |
Why?
| | Female | 26 | 2023 | 59507 | 0.240 |
Why?
| | Nucleoside Deaminases | 1 | 2004 | 2 | 0.240 |
Why?
| | Linkage Disequilibrium | 1 | 2005 | 245 | 0.240 |
Why?
| | DNA | 3 | 2004 | 1351 | 0.230 |
Why?
| | Carcinogenesis | 2 | 2016 | 180 | 0.230 |
Why?
| | Nucleic Acid Hybridization | 2 | 2003 | 187 | 0.230 |
Why?
| | Tooth Abnormalities | 1 | 2023 | 12 | 0.230 |
Why?
| | Mice | 10 | 2021 | 14916 | 0.220 |
Why?
| | Virion | 2 | 2021 | 73 | 0.220 |
Why?
| | Bone Diseases, Developmental | 1 | 2023 | 12 | 0.220 |
Why?
| | Megalencephaly | 1 | 2023 | 15 | 0.220 |
Why?
| | Codon, Terminator | 1 | 2003 | 21 | 0.220 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2016 | 132 | 0.220 |
Why?
| | Alzheimer Disease | 3 | 2003 | 443 | 0.220 |
Why?
| | RNA Viruses | 2 | 2019 | 28 | 0.220 |
Why?
| | Virology | 1 | 2023 | 19 | 0.220 |
Why?
| | Vaginal Neoplasms | 1 | 2023 | 11 | 0.210 |
Why?
| | Cafe-au-Lait Spots | 1 | 2023 | 3 | 0.210 |
Why?
| | HIV | 1 | 2004 | 208 | 0.210 |
Why?
| | Infant | 7 | 2021 | 7935 | 0.210 |
Why?
| | Orthomyxoviridae Infections | 1 | 2023 | 54 | 0.210 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2023 | 123 | 0.210 |
Why?
| | Macaca | 1 | 2022 | 50 | 0.210 |
Why?
| | Mutagenesis, Insertional | 2 | 2018 | 61 | 0.210 |
Why?
| | Birds | 1 | 2023 | 77 | 0.210 |
Why?
| | Universities | 2 | 2023 | 339 | 0.200 |
Why?
| | Oligonucleotides | 1 | 2003 | 137 | 0.200 |
Why?
| | Flow Cytometry | 2 | 2016 | 1086 | 0.200 |
Why?
| | Wilms Tumor | 1 | 2023 | 69 | 0.200 |
Why?
| | Neoplasms | 1 | 2015 | 2105 | 0.190 |
Why?
| | Genome-Wide Association Study | 3 | 2019 | 1197 | 0.190 |
Why?
| | Asymptomatic Infections | 1 | 2021 | 21 | 0.190 |
Why?
| | Macaca mulatta | 2 | 2019 | 131 | 0.190 |
Why?
| | Pedigree | 4 | 2017 | 464 | 0.190 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2021 | 34 | 0.190 |
Why?
| | Ubiquitination | 2 | 2019 | 86 | 0.190 |
Why?
| | Glycosylation | 2 | 2019 | 130 | 0.180 |
Why?
| | Urinary Tract | 1 | 2021 | 36 | 0.180 |
Why?
| | Viral Nonstructural Proteins | 2 | 2020 | 54 | 0.180 |
Why?
| | Acute Disease | 1 | 2023 | 912 | 0.180 |
Why?
| | Chromosomes, Human, X | 1 | 2021 | 60 | 0.180 |
Why?
| | Chromosome Disorders | 1 | 2021 | 35 | 0.180 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2021 | 67 | 0.180 |
Why?
| | Kidney Tubules | 1 | 2021 | 107 | 0.180 |
Why?
| | Blepharophimosis | 1 | 2020 | 3 | 0.180 |
Why?
| | Databases, Genetic | 3 | 2014 | 206 | 0.180 |
Why?
| | Crowdsourcing | 1 | 2020 | 16 | 0.170 |
Why?
| | Pandemics | 3 | 2023 | 1319 | 0.170 |
Why?
| | Receptors, CCR5 | 2 | 2017 | 54 | 0.170 |
Why?
| | Specimen Handling | 1 | 2021 | 156 | 0.170 |
Why?
| | Eczema | 1 | 2020 | 81 | 0.170 |
Why?
| | RNA Virus Infections | 1 | 2019 | 11 | 0.170 |
Why?
| | DNA Primers | 2 | 2015 | 514 | 0.170 |
Why?
| | DNA Helicases | 1 | 2000 | 134 | 0.170 |
Why?
| | RNA, Double-Stranded | 1 | 2019 | 44 | 0.170 |
Why?
| | Developmental Disabilities | 2 | 2023 | 239 | 0.170 |
Why?
| | Flavivirus Infections | 1 | 2019 | 9 | 0.170 |
Why?
| | env Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 16 | 0.170 |
Why?
| | Male | 16 | 2021 | 55579 | 0.170 |
Why?
| | Models, Genetic | 4 | 2006 | 565 | 0.160 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2019 | 56 | 0.160 |
Why?
| | Cytidine Deaminase | 2 | 2013 | 58 | 0.160 |
Why?
| | Histone Deacetylases | 1 | 2020 | 195 | 0.160 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2019 | 33 | 0.160 |
Why?
| | Kidney Neoplasms | 1 | 2023 | 333 | 0.160 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2019 | 134 | 0.160 |
Why?
| | Ontario | 3 | 2023 | 74 | 0.160 |
Why?
| | Viral Structural Proteins | 1 | 2018 | 12 | 0.160 |
Why?
| | Myofibromatosis | 1 | 2018 | 6 | 0.160 |
Why?
| | HIV Seropositivity | 1 | 2019 | 109 | 0.160 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 25 | 0.160 |
Why?
| | Alopecia | 1 | 2018 | 28 | 0.150 |
Why?
| | Nucleotidyltransferases | 1 | 2018 | 26 | 0.150 |
Why?
| | Young Adult | 7 | 2021 | 10463 | 0.150 |
Why?
| | Sequence Homology | 1 | 2018 | 39 | 0.150 |
Why?
| | Infant, Newborn | 4 | 2018 | 5035 | 0.150 |
Why?
| | DNA, Fungal | 1 | 2018 | 69 | 0.150 |
Why?
| | Exons | 2 | 2020 | 303 | 0.150 |
Why?
| | DEAD Box Protein 58 | 1 | 2017 | 8 | 0.150 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 344 | 0.150 |
Why?
| | Africa | 1 | 2018 | 95 | 0.150 |
Why?
| | SUMO-1 Protein | 1 | 2017 | 19 | 0.150 |
Why?
| | Acetyltransferases | 1 | 2017 | 20 | 0.140 |
Why?
| | Charcot-Marie-Tooth Disease | 1 | 2017 | 19 | 0.140 |
Why?
| | Membrane Transport Proteins | 1 | 2018 | 138 | 0.140 |
Why?
| | Adult | 8 | 2017 | 30548 | 0.140 |
Why?
| | Callithrix | 1 | 2016 | 8 | 0.140 |
Why?
| | Hylobates | 1 | 2016 | 8 | 0.140 |
Why?
| | Pongo | 1 | 2016 | 6 | 0.140 |
Why?
| | Pathology, Molecular | 1 | 2017 | 26 | 0.140 |
Why?
| | Autism Spectrum Disorder | 2 | 2021 | 323 | 0.140 |
Why?
| | Totivirus | 1 | 2016 | 1 | 0.140 |
Why?
| | Intelligence | 1 | 2017 | 131 | 0.140 |
Why?
| | Signal Transduction | 4 | 2015 | 4522 | 0.140 |
Why?
| | Interferons | 1 | 2017 | 151 | 0.140 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1691 | 0.140 |
Why?
| | Receptors, Immunologic | 1 | 2017 | 201 | 0.140 |
Why?
| | Chondroblastoma | 1 | 2016 | 4 | 0.140 |
Why?
| | Brachydactyly | 1 | 2016 | 1 | 0.140 |
Why?
| | Spastic Paraplegia, Hereditary | 1 | 2016 | 6 | 0.130 |
Why?
| | Spinocerebellar Ataxias | 1 | 2016 | 4 | 0.130 |
Why?
| | Dysarthria | 1 | 2016 | 9 | 0.130 |
Why?
| | Immunoprecipitation | 1 | 2016 | 152 | 0.130 |
Why?
| | Genetic Association Studies | 2 | 2015 | 344 | 0.130 |
Why?
| | Immunoblotting | 1 | 2016 | 283 | 0.130 |
Why?
| | Capsid | 3 | 2012 | 75 | 0.130 |
Why?
| | White Matter | 1 | 2017 | 104 | 0.130 |
Why?
| | Filoviridae | 1 | 2015 | 6 | 0.130 |
Why?
| | Antiviral Agents | 2 | 2021 | 646 | 0.130 |
Why?
| | Peptide Chain Elongation, Translational | 1 | 2015 | 18 | 0.130 |
Why?
| | Adolescent | 9 | 2021 | 17808 | 0.130 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2016 | 345 | 0.130 |
Why?
| | Protein Interaction Mapping | 1 | 2016 | 101 | 0.130 |
Why?
| | Tuberculosis | 1 | 2018 | 241 | 0.130 |
Why?
| | Disease Resistance | 1 | 2015 | 27 | 0.130 |
Why?
| | Heat-Shock Proteins | 1 | 2016 | 113 | 0.130 |
Why?
| | Magnetic Resonance Imaging | 2 | 2017 | 3039 | 0.130 |
Why?
| | Muscle Spasticity | 1 | 2016 | 53 | 0.130 |
Why?
| | Myositis Ossificans | 1 | 2015 | 6 | 0.130 |
Why?
| | Activin Receptors, Type I | 1 | 2015 | 9 | 0.130 |
Why?
| | Molecular Docking Simulation | 1 | 2015 | 101 | 0.120 |
Why?
| | Colorado | 2 | 2023 | 4086 | 0.120 |
Why?
| | Hallux Valgus | 1 | 2015 | 27 | 0.120 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2014 | 8 | 0.120 |
Why?
| | Blotting, Western | 2 | 2016 | 1151 | 0.120 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 621 | 0.120 |
Why?
| | Craniofacial Abnormalities | 1 | 2015 | 59 | 0.120 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 386 | 0.120 |
Why?
| | Acclimatization | 1 | 2016 | 150 | 0.120 |
Why?
| | Gene Expression | 2 | 2011 | 1420 | 0.120 |
Why?
| | Ribosomes | 1 | 2015 | 148 | 0.120 |
Why?
| | Vesicle-Associated Membrane Protein 1 | 1 | 2014 | 2 | 0.120 |
Why?
| | Sarcoma | 1 | 2016 | 138 | 0.120 |
Why?
| | Transfection | 1 | 2016 | 870 | 0.120 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 193 | 0.120 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2014 | 5 | 0.120 |
Why?
| | HIV-2 | 1 | 2014 | 15 | 0.120 |
Why?
| | Gene Rearrangement | 1 | 2015 | 138 | 0.120 |
Why?
| | Syndrome | 1 | 2015 | 334 | 0.120 |
Why?
| | Morphogenesis | 1 | 2015 | 161 | 0.120 |
Why?
| | Mass Screening | 1 | 2021 | 1003 | 0.120 |
Why?
| | Siblings | 1 | 2015 | 222 | 0.120 |
Why?
| | Hemiplegia | 1 | 2014 | 18 | 0.110 |
Why?
| | Chromosome Mapping | 3 | 2005 | 489 | 0.110 |
Why?
| | Dystonic Disorders | 1 | 2014 | 16 | 0.110 |
Why?
| | Bone Neoplasms | 1 | 2016 | 194 | 0.110 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2015 | 102 | 0.110 |
Why?
| | Consanguinity | 1 | 2014 | 47 | 0.110 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 43 | 0.110 |
Why?
| | Botulinum Toxins | 1 | 2014 | 39 | 0.110 |
Why?
| | Peer Review, Research | 1 | 2014 | 34 | 0.110 |
Why?
| | Biomarkers | 1 | 2023 | 3416 | 0.110 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 429 | 0.110 |
Why?
| | Chromosomal Proteins, Non-Histone | 3 | 2004 | 100 | 0.110 |
Why?
| | Gene Library | 1 | 2013 | 114 | 0.110 |
Why?
| | Brain | 3 | 2015 | 2374 | 0.110 |
Why?
| | Middle Aged | 5 | 2017 | 26757 | 0.110 |
Why?
| | Nervous System Malformations | 1 | 2013 | 34 | 0.110 |
Why?
| | Adaptation, Biological | 1 | 2013 | 54 | 0.110 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2023 | 863 | 0.110 |
Why?
| | Amphibians | 1 | 2013 | 47 | 0.100 |
Why?
| | Neoplastic Stem Cells | 1 | 2016 | 334 | 0.100 |
Why?
| | Parvovirus, Canine | 1 | 2012 | 1 | 0.100 |
Why?
| | Canidae | 1 | 2012 | 1 | 0.100 |
Why?
| | Parvoviridae Infections | 1 | 2012 | 11 | 0.100 |
Why?
| | Hospitalization | 1 | 2021 | 1752 | 0.100 |
Why?
| | DNA Mutational Analysis | 4 | 2014 | 372 | 0.100 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 1 | 2012 | 26 | 0.100 |
Why?
| | Cluster Analysis | 1 | 2013 | 460 | 0.100 |
Why?
| | Endoribonucleases | 2 | 2022 | 62 | 0.100 |
Why?
| | Iron | 1 | 2013 | 234 | 0.100 |
Why?
| | Family Health | 1 | 2012 | 194 | 0.100 |
Why?
| | Chordata | 1 | 2011 | 5 | 0.100 |
Why?
| | Gene Dosage | 1 | 2011 | 134 | 0.090 |
Why?
| | Lung | 1 | 2023 | 3546 | 0.090 |
Why?
| | DNA Polymerase beta | 1 | 2010 | 5 | 0.090 |
Why?
| | Retroviridae Infections | 2 | 2009 | 46 | 0.090 |
Why?
| | Immunity, Innate | 2 | 2018 | 723 | 0.090 |
Why?
| | Endonucleases | 1 | 2010 | 30 | 0.090 |
Why?
| | Epilepsy | 1 | 2014 | 277 | 0.090 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2010 | 30 | 0.090 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 325 | 0.090 |
Why?
| | Endodeoxyribonucleases | 1 | 2010 | 59 | 0.090 |
Why?
| | Fetal Growth Retardation | 1 | 2015 | 467 | 0.090 |
Why?
| | Disease Models, Animal | 1 | 2019 | 3542 | 0.090 |
Why?
| | Gene Conversion | 1 | 1989 | 6 | 0.090 |
Why?
| | Pregnancy | 1 | 2021 | 5525 | 0.080 |
Why?
| | Vero Cells | 2 | 2019 | 63 | 0.080 |
Why?
| | Genetic Techniques | 1 | 1989 | 58 | 0.080 |
Why?
| | Survival Rate | 1 | 2013 | 1642 | 0.080 |
Why?
| | Rodentia | 1 | 2009 | 44 | 0.080 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 2725 | 0.080 |
Why?
| | Statistics as Topic | 1 | 1989 | 294 | 0.080 |
Why?
| | Estrogens | 1 | 2011 | 312 | 0.080 |
Why?
| | Algorithms | 1 | 2015 | 1468 | 0.080 |
Why?
| | Chromosome Deletion | 2 | 2021 | 95 | 0.080 |
Why?
| | Reverse Transcription | 1 | 2007 | 18 | 0.070 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2007 | 41 | 0.070 |
Why?
| | Binding Sites | 1 | 2010 | 1176 | 0.070 |
Why?
| | Minichromosome Maintenance Proteins | 2 | 2004 | 3 | 0.070 |
Why?
| | Prospective Studies | 3 | 2023 | 6217 | 0.070 |
Why?
| | Genetics, Population | 2 | 2006 | 188 | 0.070 |
Why?
| | Adaptation, Physiological | 1 | 2010 | 483 | 0.070 |
Why?
| | Students | 2 | 2023 | 501 | 0.070 |
Why?
| | Meiosis | 1 | 2006 | 59 | 0.070 |
Why?
| | Genomic Instability | 1 | 2006 | 38 | 0.070 |
Why?
| | Biomarkers, Tumor | 2 | 2022 | 1053 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1745 | 0.060 |
Why?
| | Point Mutation | 2 | 2018 | 216 | 0.060 |
Why?
| | Cattle | 1 | 2007 | 921 | 0.060 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2004 | 18 | 0.060 |
Why?
| | APOBEC-1 Deaminase | 1 | 2004 | 5 | 0.060 |
Why?
| | APOBEC-3G Deaminase | 1 | 2004 | 6 | 0.060 |
Why?
| | APOBEC Deaminases | 1 | 2004 | 5 | 0.060 |
Why?
| | vif Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 4 | 0.060 |
Why?
| | Gene Products, vif | 1 | 2004 | 2 | 0.060 |
Why?
| | Cats | 2 | 2019 | 193 | 0.060 |
Why?
| | RNA Editing | 1 | 2004 | 20 | 0.060 |
Why?
| | Minichromosome Maintenance Complex Component 7 | 2 | 2000 | 4 | 0.060 |
Why?
| | Likelihood Functions | 1 | 2004 | 126 | 0.060 |
Why?
| | rab5 GTP-Binding Proteins | 1 | 2023 | 6 | 0.060 |
Why?
| | DNA Transposable Elements | 1 | 2004 | 101 | 0.060 |
Why?
| | Risk Factors | 3 | 2012 | 8627 | 0.060 |
Why?
| | Catalysis | 1 | 2004 | 292 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2003 | 108 | 0.050 |
Why?
| | rab GTP-Binding Proteins | 1 | 2023 | 63 | 0.050 |
Why?
| | Plant Viruses | 1 | 2003 | 7 | 0.050 |
Why?
| | Sequence Deletion | 1 | 2003 | 167 | 0.050 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2004 | 218 | 0.050 |
Why?
| | Muscle Proteins | 1 | 2004 | 210 | 0.050 |
Why?
| | Monkeypox virus | 1 | 2022 | 12 | 0.050 |
Why?
| | Masks | 1 | 2023 | 46 | 0.050 |
Why?
| | Genetic Markers | 1 | 2003 | 321 | 0.050 |
Why?
| | Cytoplasm | 1 | 2022 | 255 | 0.050 |
Why?
| | Neuroimaging | 1 | 2023 | 249 | 0.050 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 92 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2007 | 1521 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 743 | 0.050 |
Why?
| | Observational Studies as Topic | 1 | 2021 | 90 | 0.050 |
Why?
| | Attitude | 1 | 2023 | 229 | 0.050 |
Why?
| | Minichromosome Maintenance Complex Component 4 | 1 | 2000 | 1 | 0.050 |
Why?
| | Minichromosome Maintenance Complex Component 3 | 1 | 2000 | 2 | 0.050 |
Why?
| | Arachis | 1 | 2003 | 146 | 0.050 |
Why?
| | Oligopeptides | 1 | 2022 | 234 | 0.050 |
Why?
| | Haploinsufficiency | 1 | 2021 | 42 | 0.050 |
Why?
| | B-Lymphocytes | 1 | 2006 | 769 | 0.050 |
Why?
| | Retrospective Studies | 2 | 2014 | 12515 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2021 | 249 | 0.040 |
Why?
| | Caenorhabditis elegans | 1 | 2023 | 269 | 0.040 |
Why?
| | Dimerization | 1 | 2000 | 176 | 0.040 |
Why?
| | Knowledge Bases | 1 | 2020 | 17 | 0.040 |
Why?
| | Geminiviridae | 1 | 1999 | 1 | 0.040 |
Why?
| | Zebrafish | 1 | 2023 | 411 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2000 | 197 | 0.040 |
Why?
| | DNA Copy Number Variations | 1 | 2020 | 158 | 0.040 |
Why?
| | Disease Outbreaks | 1 | 2022 | 309 | 0.040 |
Why?
| | Histone Acetyltransferases | 1 | 2020 | 51 | 0.040 |
Why?
| | Flavivirus | 1 | 2019 | 16 | 0.040 |
Why?
| | HeLa Cells | 1 | 2000 | 562 | 0.040 |
Why?
| | Skull | 1 | 2020 | 119 | 0.040 |
Why?
| | Cloning, Molecular | 2 | 2011 | 524 | 0.040 |
Why?
| | Philippines | 1 | 2018 | 50 | 0.040 |
Why?
| | Proteolysis | 1 | 2019 | 143 | 0.040 |
Why?
| | Nucleotides, Cyclic | 1 | 2018 | 15 | 0.040 |
Why?
| | DNA Replication | 1 | 2000 | 205 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2003 | 1796 | 0.040 |
Why?
| | Substrate Specificity | 1 | 2019 | 354 | 0.040 |
Why?
| | Genes, Recessive | 1 | 2018 | 73 | 0.040 |
Why?
| | Capsid Proteins | 2 | 2012 | 69 | 0.040 |
Why?
| | Age Distribution | 1 | 2018 | 339 | 0.040 |
Why?
| | Pilot Projects | 1 | 2022 | 1370 | 0.040 |
Why?
| | Encephalitis, Viral | 1 | 1997 | 39 | 0.040 |
Why?
| | Herpes Simplex | 1 | 1997 | 87 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 1214 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 521 | 0.030 |
Why?
| | Machine Learning | 1 | 2020 | 318 | 0.030 |
Why?
| | DNA Methylation | 1 | 2021 | 496 | 0.030 |
Why?
| | Langer-Giedion Syndrome | 1 | 2016 | 2 | 0.030 |
Why?
| | Hair Diseases | 1 | 2016 | 6 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2019 | 436 | 0.030 |
Why?
| | Cycloheximide | 1 | 2015 | 54 | 0.030 |
Why?
| | Nose | 1 | 2016 | 55 | 0.030 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2016 | 40 | 0.030 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2015 | 42 | 0.030 |
Why?
| | Methyltransferases | 1 | 2016 | 61 | 0.030 |
Why?
| | Population Surveillance | 1 | 2018 | 392 | 0.030 |
Why?
| | Fingers | 1 | 2016 | 83 | 0.030 |
Why?
| | Methylation | 1 | 2016 | 208 | 0.030 |
Why?
| | Methionine | 1 | 2016 | 144 | 0.030 |
Why?
| | Codon | 1 | 2015 | 86 | 0.030 |
Why?
| | Guanylate Kinases | 1 | 2015 | 13 | 0.030 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2015 | 27 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2018 | 2582 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1361 | 0.030 |
Why?
| | RNA, Transfer | 1 | 2015 | 118 | 0.030 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2015 | 45 | 0.030 |
Why?
| | Prognosis | 1 | 2022 | 3334 | 0.030 |
Why?
| | Thyroid Gland | 1 | 2015 | 84 | 0.030 |
Why?
| | Nucleosomes | 1 | 2016 | 122 | 0.030 |
Why?
| | Diaphragm | 1 | 2014 | 31 | 0.030 |
Why?
| | SAM Domain and HD Domain-Containing Protein 1 | 1 | 2014 | 4 | 0.030 |
Why?
| | Deoxyribonucleotides | 1 | 2014 | 17 | 0.030 |
Why?
| | Paresis | 1 | 2014 | 28 | 0.030 |
Why?
| | Myopathies, Structural, Congenital | 1 | 2014 | 6 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2015 | 284 | 0.030 |
Why?
| | Interferon-gamma | 1 | 1997 | 722 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 242 | 0.030 |
Why?
| | Long Interspersed Nucleotide Elements | 1 | 2014 | 25 | 0.030 |
Why?
| | Time Factors | 1 | 2004 | 6124 | 0.030 |
Why?
| | Financing, Organized | 1 | 2014 | 33 | 0.030 |
Why?
| | Uterus | 1 | 2015 | 192 | 0.030 |
Why?
| | Rats | 2 | 2014 | 4943 | 0.030 |
Why?
| | Cytokines | 1 | 2021 | 1843 | 0.030 |
Why?
| | Brain Diseases | 1 | 2014 | 124 | 0.030 |
Why?
| | RING Finger Domains | 1 | 2013 | 2 | 0.030 |
Why?
| | Meta-Analysis as Topic | 1 | 2014 | 161 | 0.030 |
Why?
| | Loss of Heterozygosity | 1 | 2013 | 40 | 0.030 |
Why?
| | Fibroblasts | 1 | 2017 | 838 | 0.030 |
Why?
| | Receptors, CXCR4 | 1 | 2013 | 78 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4409 | 0.030 |
Why?
| | Risk | 1 | 2015 | 815 | 0.030 |
Why?
| | Transferrin | 1 | 2012 | 40 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 262 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 4710 | 0.020 |
Why?
| | Motor Neurons | 1 | 2014 | 212 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 1992 | 24 | 0.020 |
Why?
| | CHO Cells | 1 | 2012 | 138 | 0.020 |
Why?
| | Erythropoiesis | 1 | 1992 | 34 | 0.020 |
Why?
| | Cricetinae | 1 | 2012 | 254 | 0.020 |
Why?
| | Penetrance | 1 | 2011 | 27 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2012 | 198 | 0.020 |
Why?
| | Erythropoietin | 1 | 1992 | 72 | 0.020 |
Why?
| | Aromatase | 1 | 2011 | 30 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2016 | 1147 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2011 | 257 | 0.020 |
Why?
| | Neurons | 1 | 1997 | 1281 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 3890 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2011 | 405 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2014 | 2209 | 0.020 |
Why?
| | Models, Statistical | 2 | 2004 | 604 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 1989 | 157 | 0.020 |
Why?
| | Family | 1 | 2013 | 591 | 0.020 |
Why?
| | Hematopoietic Stem Cells | 1 | 1992 | 345 | 0.020 |
Why?
| | Apoptosis | 1 | 1997 | 2369 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2011 | 372 | 0.020 |
Why?
| | Heart Defects, Congenital | 1 | 2014 | 665 | 0.020 |
Why?
| | Comorbidity | 1 | 2011 | 1449 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2006 | 38 | 0.020 |
Why?
| | Aged | 2 | 2015 | 19094 | 0.020 |
Why?
| | Escherichia coli | 1 | 1989 | 722 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2015 | 6350 | 0.010 |
Why?
| | Cohort Studies | 1 | 2014 | 4901 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 1989 | 739 | 0.010 |
Why?
| | Africa, Western | 1 | 2003 | 16 | 0.010 |
Why?
| | India | 1 | 2003 | 134 | 0.010 |
Why?
| | Open Reading Frames | 1 | 2003 | 116 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2003 | 218 | 0.010 |
Why?
| | Sweden | 1 | 2001 | 65 | 0.010 |
Why?
| | Sample Size | 1 | 2001 | 114 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2001 | 297 | 0.010 |
Why?
| | Two-Hybrid System Techniques | 1 | 2000 | 52 | 0.010 |
Why?
| | G1 Phase | 1 | 2000 | 68 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2000 | 140 | 0.010 |
Why?
| | Gene Deletion | 1 | 2001 | 356 | 0.010 |
Why?
| | Plasmids | 1 | 2000 | 345 | 0.010 |
Why?
| | Temperature | 1 | 2000 | 575 | 0.010 |
Why?
| | Cell Cycle | 1 | 2000 | 543 | 0.010 |
Why?
| | Antigens, Viral | 1 | 1997 | 176 | 0.010 |
Why?
| | Interleukin-4 | 1 | 1997 | 208 | 0.010 |
Why?
| | Eye | 1 | 1997 | 101 | 0.010 |
Why?
| | Chromatin | 1 | 2000 | 428 | 0.010 |
Why?
| | Defective Viruses | 1 | 1992 | 4 | 0.010 |
Why?
| | Interleukin-3 | 1 | 1992 | 23 | 0.010 |
Why?
| | Receptors, Erythropoietin | 1 | 1992 | 22 | 0.010 |
Why?
| | Gene Expression Regulation, Viral | 1 | 1992 | 80 | 0.010 |
Why?
| | Fluorouracil | 1 | 1992 | 152 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1992 | 617 | 0.010 |
Why?
| | Inflammation | 1 | 1997 | 2481 | 0.000 |
Why?
|
|
Sawyer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|